The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias

OBJECTIVE: Although lung squamous cell carcinoma (SCC) accounts for 20-30% of lung cancer cases, new treatment options are limited. The CA031 study showed that nanoparticle albumin-bound-paclitaxel (nab-PTX) plus carboplatin produced a significantly higher overall response rate (41%) than solvent-ba...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Fujita, Tetsuo, Hiroishi, Takuma, Shikano, Kohei, Yanagisawa, Asako, Hayama, Noriko, Amano, Hiroyuki, Nakamura, Makoto, Hirano, Satoshi, Tabeta, Hiroshi, Nakamura, Sukeyuki
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064686/
https://ncbi.nlm.nih.gov/pubmed/29434143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0404-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars